SPECTRUM PHARMACEUTICALS INC Accounts Receivable
SPECTRUM PHARMACEUTICALS INC had Accounts Receivable of $32.76 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-05-11
- 2023-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $32.76M.
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $13.00M.
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2021-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2023-03-31 | $32.76M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $13.00M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $64.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $67.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | $453.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $441.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $435.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $441.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $483.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.54M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $14.94M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $29.87M 10-K · filed 2020-03-02 |
| 2018-09-30 | $29.48M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $27.66M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $33.38M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $32.26M 10-K · filed 2019-02-28 |
| 2017-09-30 | $37.77M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $41.98M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $39.49M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $39.78M 10-K · filed 2018-03-07 |
| 2016-09-30 | $42.47M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $34.32M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $19.25M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $30.38M 10-K · filed 2017-03-14 |
| 2015-09-30 | $48.15M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $41.68M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $68.75M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $70.76M 10-K · filed 2016-03-14 |
| 2014-09-30 | $60.09M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $56.74M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $54.01M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $49.48M 10-K · filed 2015-03-13 |
| 2013-09-30 | $54.92M 10-Q · filed 2013-11-18 |
| 2013-06-30 | $52.38M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $39.43M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $92.17M 10-K · filed 2014-03-12 |
| 2012-09-30 | $90.94M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $84.84M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $55.38M 10-Q · filed 2012-04-27 |
| 2011-12-31 | $51.70M 10-K · filed 2013-02-28 |
| 2011-09-30 | $47.77M 10-Q · filed 2011-10-28 |
| 2011-06-30 | $46.47M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $21.05M 10-K · filed 2012-03-02 |